KR101534661B1 - ３（이미다졸릴）피라졸로〔３，４ｂ〕피리딘 - Google Patents
３（이미다졸릴）피라졸로〔３，４ｂ〕피리딘 Download PDFInfo
- Publication number
- KR101534661B1 KR101534661B1 KR1020097026765A KR20097026765A KR101534661B1 KR 101534661 B1 KR101534661 B1 KR 101534661B1 KR 1020097026765 A KR1020097026765 A KR 1020097026765A KR 20097026765 A KR20097026765 A KR 20097026765A KR 101534661 B1 KR101534661 B1 KR 101534661B1
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- disease
- compounds
- pyrazolo
- acid
- Prior art date
Links
- 0 *c(c(*)c1)cc(*)c1N(CC1)CCN1C(C[n](c1c2cccn1)nc2C1=N*C=C*1)=O Chemical compound *c(c(*)c1)cc(*)c1N(CC1)CCN1C(C[n](c1c2cccn1)nc2C1=N*C=C*1)=O 0.000 description 1
- BCALDKXBXSNSBC-UHFFFAOYSA-N CC(C)(C)OC(N(CC1)CCN1c(cc1)cc(OC)c1Cl)=O Chemical compound CC(C)(C)OC(N(CC1)CCN1c(cc1)cc(OC)c1Cl)=O BCALDKXBXSNSBC-UHFFFAOYSA-N 0.000 description 1
- ZIMLRKWQDLVPEK-UHFFFAOYSA-N COc(cc(cc1)N(CC2)CCN2C(C[n](c2c3cccn2)nc3-c2ncc[nH]2)=O)c1Cl Chemical compound COc(cc(cc1)N(CC2)CCN2C(C[n](c2c3cccn2)nc3-c2ncc[nH]2)=O)c1Cl ZIMLRKWQDLVPEK-UHFFFAOYSA-N 0.000 description 1
- YMAVACUOLRGMRE-UHFFFAOYSA-N COc(cc(cc1)N2CCNCC2)c1Cl Chemical compound COc(cc(cc1)N2CCNCC2)c1Cl YMAVACUOLRGMRE-UHFFFAOYSA-N 0.000 description 1
- NBQAALDJXSWCPK-UHFFFAOYSA-N O=C(C[n](c1c2cccn1)nc2-c1ncc[nH]1)N(CC1)CCN1c(cc1)cc(C(F)(F)F)c1Cl Chemical compound O=C(C[n](c1c2cccn1)nc2-c1ncc[nH]1)N(CC1)CCN1c(cc1)cc(C(F)(F)F)c1Cl NBQAALDJXSWCPK-UHFFFAOYSA-N 0.000 description 1
- TUGUWSNQVPXKIK-UHFFFAOYSA-N O=C(C[n](c1c2cccn1)nc2-c1ncc[nH]1)N(CC1)CCN1c(cc1)cc(OCCF)c1Cl Chemical compound O=C(C[n](c1c2cccn1)nc2-c1ncc[nH]1)N(CC1)CCN1c(cc1)cc(OCCF)c1Cl TUGUWSNQVPXKIK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93294807P | 2007-05-22 | 2007-05-22 | |
| US60/932,948 | 2007-05-22 | ||
| PCT/US2008/064374 WO2008147815A1 (en) | 2007-05-22 | 2008-05-21 | 3-(imidazolyl)-pyrazolo[3,4-b]pyridines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20100022998A KR20100022998A (ko) | 2010-03-03 |
| KR101534661B1 true KR101534661B1 (ko) | 2015-07-09 |
Family
ID=40075474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020097026765A KR101534661B1 (ko) | 2007-05-22 | 2008-05-21 | ３（이미다졸릴）피라졸로〔３，４ｂ〕피리딘 |
Country Status (27)
| Country | Link |
|---|---|
| US (4) | US7629344B2 (ru) |
| EP (1) | EP2155712B1 (ru) |
| JP (1) | JP5457338B2 (ru) |
| KR (1) | KR101534661B1 (ru) |
| CN (1) | CN101743238B (ru) |
| AR (2) | AR066701A1 (ru) |
| AU (1) | AU2008256862B2 (ru) |
| BR (1) | BRPI0811849A8 (ru) |
| CA (1) | CA2687625C (ru) |
| CL (1) | CL2008001493A1 (ru) |
| CO (1) | CO6241152A2 (ru) |
| DK (1) | DK2155712T3 (ru) |
| EA (1) | EA015529B1 (ru) |
| ES (1) | ES2600477T3 (ru) |
| HK (1) | HK1141524A1 (ru) |
| HU (1) | HUE032273T2 (ru) |
| IL (1) | IL202248A (ru) |
| JO (1) | JO3319B1 (ru) |
| MA (1) | MA31442B1 (ru) |
| MX (1) | MX2009012567A (ru) |
| NZ (1) | NZ581405A (ru) |
| PE (1) | PE20090293A1 (ru) |
| PL (1) | PL2155712T3 (ru) |
| PT (1) | PT2155712T (ru) |
| TW (1) | TWI418353B (ru) |
| UA (1) | UA99619C2 (ru) |
| WO (1) | WO2008147815A1 (ru) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7777035B2 (en) * | 2005-06-22 | 2010-08-17 | Chemocentryx, Inc. | Azaindazole compounds and methods of use |
| KR20090045233A (ko) | 2006-07-10 | 2009-05-07 | 파이온 유케이 리미티드 | 속효형 벤조디아제핀 염 및 이의 중합체 형태 |
| NZ581405A (en) * | 2007-05-22 | 2011-06-30 | Chemocentryx Inc | 3-(Imidazolyl)-pyrazolo[3,4-b]pyridines and their use in treating CCR1-mediated disorders |
| KR101743140B1 (ko) * | 2008-09-11 | 2017-06-02 | 케모센트릭스, 인크. | ４-아미노-３-(이미다졸릴)-피라졸로〔３,４-ｄ〕피리미딘 |
| EP2305647A1 (en) | 2009-09-18 | 2011-04-06 | PAION UK Limited | Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process |
| EP2450039A1 (en) | 2010-11-08 | 2012-05-09 | PAION UK Ltd. | Dosing regimen for sedation with CNS 7056 (Remimazolam) |
| MX367436B (es) * | 2012-08-27 | 2019-08-21 | Chemocentryx Inc | Antagonistas de los receptores de quimiocina. |
| US9328116B2 (en) * | 2012-12-07 | 2016-05-03 | Chemocentryx, Inc. | Diazole lactams |
| AR094963A1 (es) | 2013-03-04 | 2015-09-09 | Ono Pharmaceutical Co | Reacción de oxidación excelente en el índice de conversión |
| US20170195506A1 (en) * | 2015-12-30 | 2017-07-06 | Kabushiki Kaisha Toshiba | Image forming apparatus forming location free print system and print job retrieval method by the same |
| CA3019391A1 (en) | 2016-04-07 | 2017-10-12 | Chemocentryx, Inc. | Reducing tumor burden by administering ccr1 antagonists in combination with pd-1 inhibitors or pd-l1 inhibitors |
| CA3145303A1 (en) | 2019-07-10 | 2021-01-14 | Chemocentryx, Inc. | Indanes as pd-l1 inhibitors |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7524845B2 (en) * | 2005-06-22 | 2009-04-28 | Chemocentryx, Inc. | Azaindazole compounds and methods of use |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US715746A (en) * | 1902-02-25 | 1902-12-16 | Nat Tube Co | Apparatus for handling tube-plates. |
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4238497A (en) * | 1977-10-26 | 1980-12-09 | Burroughs Wellcome Co. | Imidazoline derivatives, salts thereof and their use as pesticides |
| AU518569B2 (en) * | 1979-08-07 | 1981-10-08 | Farmos-Yhtyma Oy | 4-benzyl- and 4-benzoyl imidazole derivatives |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| LU86084A1 (fr) | 1985-09-20 | 1987-04-02 | Faco Sa | Apparei de massage electrique |
| US5102417A (en) | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
| US4800882A (en) | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
| US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
| US4927942A (en) * | 1988-12-15 | 1990-05-22 | Texaco Chemical Co. | Method for the preparation of imidazoles |
| WO1990013332A1 (en) | 1989-05-11 | 1990-11-15 | Cedars-Sinai Medical Center | Stent with sustained drug delivery |
| JPH05502179A (ja) | 1990-02-28 | 1993-04-22 | メドトロニック インコーポレーテッド | 管状器官内薬剤溶出装具 |
| US5419760A (en) | 1993-01-08 | 1995-05-30 | Pdt Systems, Inc. | Medicament dispensing stent for prevention of restenosis of a blood vessel |
| US5429634A (en) | 1993-09-09 | 1995-07-04 | Pdt Systems | Biogenic implant for drug delivery and method |
| US6774278B1 (en) | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
| US5833651A (en) | 1996-11-08 | 1998-11-10 | Medtronic, Inc. | Therapeutic intraluminal stents |
| US6294192B1 (en) | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| US7589199B2 (en) * | 2002-06-12 | 2009-09-15 | Chemocentryx, Inc. | Substituted piperazines |
| US7842693B2 (en) * | 2002-06-12 | 2010-11-30 | Chemocentryx, Inc. | Substituted piperazines |
| JP4723242B2 (ja) * | 2002-06-12 | 2011-07-13 | ケモセントリックス インコーポレーティッド | 炎症および免疫障害治療用ｃｃｒ１アンタゴニストとして使用するための１−アリール−４−置換ピペラジン誘導体 |
| US20050256130A1 (en) * | 2002-06-12 | 2005-11-17 | Chemocentryx, Inc. | Substituted piperazines |
| US6770729B2 (en) | 2002-09-30 | 2004-08-03 | Medtronic Minimed, Inc. | Polymer compositions containing bioactive agents and methods for their use |
| CA2558211C (en) * | 2004-03-03 | 2013-09-03 | Chemocentryx, Inc. | Bicyclic and bridged nitrogen heterocycles |
| US7435831B2 (en) | 2004-03-03 | 2008-10-14 | Chemocentryx, Inc. | Bicyclic and bridged nitrogen heterocycles |
| US7777035B2 (en) * | 2005-06-22 | 2010-08-17 | Chemocentryx, Inc. | Azaindazole compounds and methods of use |
| KR200434921Y1 (ko) * | 2006-07-10 | 2007-01-02 | 서용석 | 야외용 간이 화장실 |
| NZ581405A (en) * | 2007-05-22 | 2011-06-30 | Chemocentryx Inc | 3-(Imidazolyl)-pyrazolo[3,4-b]pyridines and their use in treating CCR1-mediated disorders |
-
2008
- 2008-05-21 NZ NZ581405A patent/NZ581405A/en unknown
- 2008-05-21 KR KR1020097026765A patent/KR101534661B1/ko active IP Right Grant
- 2008-05-21 ES ES08756054.6T patent/ES2600477T3/es active Active
- 2008-05-21 UA UAA200913250A patent/UA99619C2/ru unknown
- 2008-05-21 EP EP08756054.6A patent/EP2155712B1/en active Active
- 2008-05-21 DK DK08756054.6T patent/DK2155712T3/en active
- 2008-05-21 WO PCT/US2008/064374 patent/WO2008147815A1/en active Application Filing
- 2008-05-21 JP JP2010509526A patent/JP5457338B2/ja active Active
- 2008-05-21 AU AU2008256862A patent/AU2008256862B2/en active Active
- 2008-05-21 US US12/124,894 patent/US7629344B2/en active Active
- 2008-05-21 PL PL08756054T patent/PL2155712T3/pl unknown
- 2008-05-21 CA CA2687625A patent/CA2687625C/en active Active
- 2008-05-21 BR BRPI0811849A patent/BRPI0811849A8/pt not_active IP Right Cessation
- 2008-05-21 PT PT87560546T patent/PT2155712T/pt unknown
- 2008-05-21 MX MX2009012567A patent/MX2009012567A/es active IP Right Grant
- 2008-05-21 EA EA200901572A patent/EA015529B1/ru not_active IP Right Cessation
- 2008-05-21 CN CN200880024760.9A patent/CN101743238B/zh active Active
- 2008-05-21 HU HUE08756054A patent/HUE032273T2/en unknown
- 2008-05-22 CL CL200801493A patent/CL2008001493A1/es unknown
- 2008-05-22 TW TW097118925A patent/TWI418353B/zh active
- 2008-05-22 PE PE2008000878A patent/PE20090293A1/es not_active Application Discontinuation
- 2008-05-22 JO JOP/2008/0231A patent/JO3319B1/ar active
- 2008-05-22 AR ARP080102179A patent/AR066701A1/es not_active Application Discontinuation
-
2009
- 2009-11-12 US US12/617,620 patent/US7960388B2/en active Active
- 2009-11-19 IL IL202248A patent/IL202248A/en active IP Right Grant
- 2009-11-20 CO CO09132269A patent/CO6241152A2/es active IP Right Grant
- 2009-12-14 MA MA32416A patent/MA31442B1/fr unknown
-
2010
- 2010-08-20 HK HK10107990.3A patent/HK1141524A1/zh unknown
-
2011
- 2011-05-09 US US13/103,993 patent/US8481545B2/en active Active
-
2013
- 2013-01-04 US US13/734,479 patent/US20130184289A1/en not_active Abandoned
-
2017
- 2017-11-06 AR ARP170103074A patent/AR110128A2/es unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7524845B2 (en) * | 2005-06-22 | 2009-04-28 | Chemocentryx, Inc. | Azaindazole compounds and methods of use |
Non-Patent Citations (4)
| Title |
|---|
| Journal of Fluorine Chemistry, Vol.127, pp.1570-1573 (2006) * |
| Journal of Fluorine Chemistry, Vol.127, pp.1570-1573 (2006)* |
| Tetrahedron, Vol.62, pp.5868-5874 (2006) * |
| Tetrahedron, Vol.62, pp.5868-5874 (2006)* |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101534661B1 (ko) | ３（이미다졸릴）피라졸로〔３，４ｂ〕피리딘 | |
| US20180250293A1 (en) | Azaindazole compounds and methods of use | |
| CA2736362C (en) | 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines | |
| EP2352501B1 (en) | Compounds for use in the treatment of osteoporosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 20180628 Year of fee payment: 4 |